A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/1997
12/11/1997	WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds
12/11/1997	WO1997046216A1 Dual component dentifrice composition for dental fluoridation
12/10/1997	EP0417209B1 Compositions and methods for administering therapeutically active compounds
12/10/1997	EP0355088B1 Sulphated polysaccharides having anti-metastatic activity
12/09/1997	US5695772 Cosmetic compositions including polyisobutene
12/04/1997	WO1997045026A1 Improvements in or relating to compositions containing creatine
12/03/1997	EP0809481A1 Novel hair relaxer compositions and method for preparing same
12/02/1997	US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693675 Alkylated amine polymers
12/02/1997	US5693314 First dentifrice containing desensitizing potassium salt, second dentifrice containing other desensitizing agent such as triclosan, the two being separate until dispensed for use
11/1997
11/27/1997	WO1997044051A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
11/27/1997	WO1997044007A2 A barrier cream comprising hexamethylenetetramine or derivative thereof
11/27/1997	CA2253459A1 A barrier cream comprising hexamethylenetetramine or derivative thereof
11/26/1997	EP0808833A2 Vitamin D3 analogs
11/26/1997	CN1166171A N-substituted piperidinyl bicyclic benzoate derivatives
11/26/1997	CN1165665A Medicinal compsn. for treatment of spur and its prepn.
11/25/1997	US5691343 Crohn*s disease
11/25/1997	US5690913 Striped tootpaste, color stability during storage
11/20/1997	WO1997042963A2 Green ointment
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	EP0806940A1 Aerosol drug formulations
11/19/1997	EP0806938A1 Carrier particles for use in dry powder inhalers
11/18/1997	US5688938 Calcium receptor-active molecules
11/18/1997	US5688512 Vaccines
11/13/1997	WO1997041884A1 Method of treatment
11/13/1997	WO1997041874A1 Phosphatidic acid-comprising compositions
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/12/1997	EP0600928B1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
11/11/1997	US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997	US5686417 Peptide T and related peptides in the treatment of HTLV-1 myelopathy and multiple sclerosis
11/06/1997	WO1997040838A1 New use
11/06/1997	WO1997040810A1 Keratin fibre modifying compositions
11/06/1997	CA2253440A1 New use
11/05/1997	EP0804922A1 Photostable screening composition containing a derivative of dibenzoylmethane and an alkyletherpolysaccharide
11/05/1997	EP0804921A1 Topical composition
11/05/1997	EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
11/05/1997	EP0804144A1 Solid protector against uv, process for its preparation and use thereof
11/05/1997	CN1163936A Recombination eukaryotic vector containing sensitinogen gene and application thereof
11/05/1997	CN1163934A Protein with thrombocytopoietic factor active
11/05/1997	CN1163933A Protein with thrombocytopoietic factor active
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5684049 HIV-inhibiting benzeneacetamide derivatives
11/04/1997	US5683972 Foaming oil-in-water emulsion
11/04/1997	US5683683 Detergents of anionic surfactants for conditioning
11/04/1997	CA2088650C Cosmetic composition
10/1997
10/30/1997	WO1997039765A1 Component b as cicatrizant
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	CA2251356A1 Component b as cicatrizant
10/29/1997	EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/28/1997	US5681552 Clear cosmetic stick composition containing a combination of anionic and non-ionic surfactants
10/23/1997	WO1997034565A3 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same
10/23/1997	DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/21/1997	US5679717 Method for removing bile salts from a patient with alkylated amine polymers
10/21/1997	US5679327 Hair straightening emulsion
10/21/1997	CA2016765C Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/19/1997	CA2203074A1 Estrogenic agents
10/16/1997	WO1997038104A1 Il-6 mutein
10/16/1997	WO1997038103A1 Il-6 mutein
10/15/1997	EP0800397A1 Bone mass anabolic composition comprising olpadronate
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/14/1997	US5677448 Sulfonamidocarboxamides
10/14/1997	US5677443 Bioavailable crystalline form of cefuroxime axetil
10/14/1997	US5677310 Hypertensive agents, migraine
10/14/1997	US5676965 Use of polydeoxyribonucleotides in diabetic neuropathies
10/14/1997	US5676930 Containing a medicine, a fluorohydrocarbon propellant, ethanol and either ascorbic or citric acid as stabilizer
10/14/1997	US5676929 Canister containing aerosol formulations containing P134a and particulate medicaments
10/09/1997	WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997	WO1997036586A1 Treatment or prophylaxis of diarrhoea
10/09/1997	WO1997036578A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997	CA2250478A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997	CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/08/1997	EP0799619A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and treatment of benign prostatic hyperplasia
10/08/1997	EP0799223A1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
10/08/1997	EP0799044A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
10/08/1997	EP0799039A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
10/08/1997	EP0652743B1 Oral compositions
10/08/1997	CN1161652A Pharmaceutical compositions
10/07/1997	US5674472 Drug delivery
10/07/1997	CA2093478C Hair care products containing n-alkoxyalkylamides
10/07/1997	CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
10/02/1997	WO1997035598A1 Pharmaceutical compositions and methods for the manufacture thereof
10/02/1997	WO1997035597A1 Acne treatment
10/02/1997	WO1997035594A1 Linseed drug
10/02/1997	CA2250383A1 Acne treatment
10/02/1997	CA2201457A1 Topical composition
10/01/1997	EP0538443B1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
10/01/1997	CN1161000A Topical ophthalmic formulations containing Doxepin derivatives for treating allergic eye diseases
09/1997
09/27/1997	CA2201088A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
09/25/1997	WO1997034644A1 Topical formulations for the treatment of nail psoriasis
09/25/1997	WO1997034593A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES
09/25/1997	WO1997034577A1 Low residue antiperspirant stick composition
09/25/1997	WO1997034565A2 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same
09/25/1997	WO1997034564A2 Treatment of chronic inflammatory intestinal diseases by a phyto-compound
09/25/1997	CA2248977A1 Topical formulations for the treatment of nail psoriasis
09/25/1997	CA2248092A1 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same

1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 295